Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 781,47 | 50 | 39.074 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 780,63 | 463 | 361.432 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 779,59 | 380 | 296.244 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 778,64 | 454 | 353.503 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 777,76 | 38 | 29.555 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 776,31 | 66 | 51.236 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 775,46 | 376 | 291.573 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 774,48 | 121 | 93.712 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 773,40 | 224 | 173.242 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 772,56 | 211 | 163.010 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 771,56 | 283 | 218.351 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 770,20 | 12 | 9.242 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 769,30 | 127 | 97.701 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 768,33 | 105 | 80.675 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 767,39 | 192 | 147.339 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 766,47 | 279 | 213.845 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 765,39 | 271 | 207.421 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 764,40 | 219 | 167.404 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 763,76 | 25 | 19.094 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 762,57 | 55 | 41.941 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 761,36 | 27 | 20.557 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 760,65 | 74 | 56.288 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 759,96 | 14 | 10.639 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 758,16 | 24 | 18.196 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 757,68 | 16 | 12.123 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 755,91 | 35 | 26.457 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 14.10.2026 | Verkauf | 753,76 | 6 | 4.523 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 13.10.2026 | Steuer-Abgabe | 754,58 | 12.853 | 9.698.617 | Form 4 |
| REGN | Murphy Andrew J | Co-Chief Scientific Officer | 13.10.2026 | Optionsausübung | 381,92 | 17.000 | 6.492.640 | Form 4 |
| REGN | McCourt Marion | EVP Commercial | 03.09.2026 | Verkauf | 857,39 | 1.131 | 969.708 | Form 4 |
| REGN | Guarini Kathryn | Director | 02.09.2026 | Verkauf | 850,00 | 400 | 340.000 | Form 4 |
| REGN | Guarini Kathryn | Director | 02.09.2026 | Optionsausübung | 719,37 | 400 | 287.748 | Form 4 |
| REGN | McCourt Marion | EVP Commercial | 02.09.2026 | Verkauf | 850,00 | 1.215 | 1.032.750 | Form 4 |
| REGN | Larosa Joseph J | EVP General Counsel and Secret | 19.08.2026 | Steuer-Abgabe | 830,15 | 9.019 | 7.487.123 | Form 4 |
| REGN | Larosa Joseph J | EVP General Counsel and Secret | 19.08.2026 | Optionsausübung | 381,92 | 12.282 | 4.690.741 | Form 4 |
| REGN | Fenimore Christopher R. | EVP Finance CFO | 18.08.2026 | Steuer-Abgabe | 813,47 | 4.599 | 3.741.149 | Form 4 |
| REGN | Fenimore Christopher R. | EVP Finance CFO | 18.08.2026 | Optionsausübung | 381,92 | 6.283 | 2.399.603 | Form 4 |
| REGN | Guarini Kathryn | Director | 10.08.2026 | Verkauf | 800,00 | 400 | 320.000 | Form 4 |
| REGN | Guarini Kathryn | Director | 10.08.2026 | Optionsausübung | 719,37 | 400 | 287.748 | Form 4 |
| REGN | Zoghbi Huda Y | Director | 10.08.2026 | Verkauf | 800,00 | 800 | 640.000 | Form 4 |
| REGN | Zoghbi Huda Y | Director | 10.08.2026 | Optionsausübung | 376,69 | 800 | 301.352 | Form 4 |
| REG | Linneman Peter | Director | 07.08.2026 | Zuteilung | — | 318 | — | Form 4 |
| REG | Klein Karin | Director | 07.08.2026 | Zuteilung | — | 382 | — | Form 4 |
| REG | Parrell Mark J. | Director | 07.08.2026 | Zuteilung | — | 334 | — | Form 4 |
| REG | Blankenship C Ronald | Director | 07.08.2026 | Zuteilung | — | 167 | — | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).